[Association of high-density lipoprotein cholesterol with risk of cardiovascular disease mortality]. 2021

J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
School of Public Health, Zhejiang University, Hangzhou 310058, China Yuecheng District Center for Disease Control and Prevention, Shaoxing 312000, China.

Objective: To analyze the association between high density lipoprotein cholesterol (HDL-C) and the risk of cardiovascular disease mortality. Methods: A total of 71 618 residents aged over 18 years with complete baseline data, who were filed on the health information big data platform of Yinzhou district, Ningbo city, Zhejiang Province from 2009 to 2014, were selected as the research population. The research population were divided into four groups according to the level of HDL-C: low-level group (HDL-C<1.0 mmol/L), intermediate-level group (1.0 mmol/L≤HDL-C<1.5 mmol/L), medium-high-level group (1.5 mmol/L≤HDL-C<2.0 mmol/L) and high-level group (HDL-C≥2.0 mmol/L). Cox proportional hazard model was used to calculate the risk ratio of cardiovascular diseases mortality in different groups. Results: The study population was followed up for a total of 427 989.4 person-years, follow-up time of (5.98±1.04)years. During the follow-up period, there were 799 deaths due to cardiovascular diseases. After adjusting for confounding factors, compared with the medium-high-level group as the reference group, the HR (95%CI) for cardiovascular diseases mortality was 1.43 (1.13-1.82) in the low-level group and 1.22 (1.02-1.46) in the high-level group. Conclusion: The low level of HDL-C (<1.5 mmol/L) is associated with a higher risk of cardiovascular disease deaths. The level of HDL-C can be used as a biological indicator to monitor the development of cardiovascular diseases and guide treatment.

UI MeSH Term Description Entries
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D016016 Proportional Hazards Models Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time. Cox Model,Cox Proportional Hazards Model,Hazard Model,Hazards Model,Hazards Models,Models, Proportional Hazards,Proportional Hazard Model,Proportional Hazards Model,Cox Models,Cox Proportional Hazards Models,Hazard Models,Proportional Hazard Models,Hazard Model, Proportional,Hazard Models, Proportional,Hazards Model, Proportional,Hazards Models, Proportional,Model, Cox,Model, Hazard,Model, Hazards,Model, Proportional Hazard,Model, Proportional Hazards,Models, Cox,Models, Hazard,Models, Hazards,Models, Proportional Hazard

Related Publications

J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
December 2013, European heart journal,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
August 2022, Heliyon,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
March 2023, Cardiovascular diabetology,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
January 2018, Journal of clinical lipidology,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
February 2023, The American journal of cardiology,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
March 2022, The American journal of cardiology,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
November 2004, Current cardiology reports,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
March 2006, American heart journal,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
August 2003, Current opinion in lipidology,
J J Bao, and T Z Li, and Z M Yang, and Y Zhu, and J M Lu, and P Shen, and H B Lin, and K Chen, and J B Wang
June 2001, Archives of internal medicine,
Copied contents to your clipboard!